AstraZeneca Seeks To Block Ex-Consultant's Testimony
AstraZeneca Pharmaceuticals Inc. moved Wednesday to block a rival from using one of its paid consultants as an expert witness in ongoing patent infringement litigation in New Jersey over a proposed...To view the full article, register now.
Already a subscriber? Click here to view full article